We use analytics cookies to give us insight into how our website is being used. Learn more in our cookie notice I Accept +

+44 (0) 20 3997 7634 | sales@fbkmed.com

Primary Esophageal Cancer: Heterogeneity as Potential Prognostic Biomarker in Patients Treated with Definitive Chemotherapy and Radiation Therapy

Primary Esophageal Cancer: Heterogeneity as Potential Prognostic Biomarker in Patients Treated with Definitive Chemotherapy and Radiation Therapy

01/01/14
Back To News +

Latest Articles

Feedback agrees new tuberculosis partnership in India

25/03/24

Bleepa Feedback Medical Feedback PLC

Feedback secures pathway pilot with Oldham CDC

21/03/24

Bleepa Feedback Medical Feedback PLC

Feedback opens opportunity in UK private healthcare

21/02/24

Bleepa Feedback Medical Feedback PLC